These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18836633)

  • 1. Tissue specific MR contrast media role in the differential diagnosis of cirrhotic liver nodules.
    Lupescu IG; Capsa RA; Gheorghe L; Herlea V; Georgescu SA
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):341-6. PubMed ID: 18836633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation.
    Hussain SM; Zondervan PE; IJzermans JN; Schalm SW; de Man RA; Krestin GP
    Radiographics; 2002; 22(5):1023-36; discussion 1037-9. PubMed ID: 12235331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR.
    Bartolozzi C; Battaglia V; Bozzi E
    Abdom Imaging; 2011 Jun; 36(3):290-9. PubMed ID: 21267561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of the liver. Cirrhosis and premalignant nodules.
    Ohtomo K
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):331-46. PubMed ID: 9113678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J; Forner A; Reig M; Vilana R; de Lope CR; Ayuso C; Bruix J
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging.
    Vitellas KM; Tzalonikou MT; Bennett WF; Vaswani KK; Bova JG
    Abdom Imaging; 2001; 26(6):601-15. PubMed ID: 11907725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.
    Hanna RF; Aguirre DA; Kased N; Emery SC; Peterson MR; Sirlin CB
    Radiographics; 2008; 28(3):747-69. PubMed ID: 18480482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
    Baron RL; Peterson MS
    Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to differentiate liver lesions in cirrhosis.
    Bartolozzi C; Crocetti L; Della Pina MC
    JBR-BTR; 2007; 90(6):475-81. PubMed ID: 18376759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation.
    Kim T; Baron RL; Nalesnik MA
    AJR Am J Roentgenol; 2000 Oct; 175(4):1121-5. PubMed ID: 11000176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications of clinical uses of contrast agents for MR imaging of liver].
    Chen F; Ni YC
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):299-300. PubMed ID: 15854502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Iron oxides as contrast agents for MRI of the liver].
    Van Beers BE; Pringot J; Gallez B
    J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of focal liver lesions.
    Jang HJ; Yu H; Kim TK
    Semin Roentgenol; 2009 Oct; 44(4):266-82. PubMed ID: 19715792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for imaging focal lesions in liver cirrhosis.
    Lencioni R; Crocetti L; Della Pina MC; Cioni D
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):697-703. PubMed ID: 19072346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of liver lesions: exceptions and atypical lesions.
    van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Preda A; Krestin GP
    Curr Probl Diagn Radiol; 2008; 37(3):95-103. PubMed ID: 18436109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-containing nodules of cirrhosis.
    Zhang J; Krinsky GA
    NMR Biomed; 2004 Nov; 17(7):459-64. PubMed ID: 15526293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
    Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.